Logo for OmniAb Inc

OmniAb Investor Relations Material

Latest events

Logo for OmniAb Inc

Q3 2024

OmniAb
Logo for OmniAb

Q3 2024

12 Nov, 2024
Logo for OmniAb

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from OmniAb Inc

Access all reports
OmniAb Inc. is a biotechnology firm specializing in the discovery and development of therapeutic antibodies. The company operates a unique discovery platform that leverages the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which are engineered to produce antibodies with human sequences. This approach facilitates the development of human therapeutic candidates. The company is headquartered in Emeryville, California, and its shares are listed on the Nasdaq.